Norcliffe Capital: Investment Portfolio & Startup News

Norcliffe Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

1 Jul 2025

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.

Norcliffe Capital

- Life Sciences
norcliffe.capital
Update Information

More venture news

XRlabs
20 Oct 2026
XRlabs raises a £6.5m seed round led by Playground Global to embed AI Surgical Intelligence into operating rooms
SeedHealth
Opply
21 Oct 2026
Opply lands a £5.5m seed round led by Chalfen Ventures to run AI operating system for consumer brands
SeedSupply Chain
Skyfly Technologies
20 Oct 2026
Skyfly Technologies lands a £7.5m seed round led by HICO Investment Group for hybrid-electric vertical takeoff aircraft
SeedMobility

Norcliffe Capital: Investment Portfolio & Startup News

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

More venture news

XRlabs raises a £6.5m seed round led by Playground Global to embed AI Surgical Intelligence into operating rooms

Opply lands a £5.5m seed round led by Chalfen Ventures to run AI operating system for consumer brands

Skyfly Technologies lands a £7.5m seed round led by HICO Investment Group for hybrid-electric vertical takeoff aircraft